Cartesian Therapeutics (RNAC) Change in Account Payables (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly Change in Account Payables came in at $310000.0 in Q1 2026, down 82.96% year-on-year from $1.8 million in Q1 2025, and up 133.23% on a QoQ basis from -$933000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Change in Account Payables (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Change in Account Payables data on file, last reported at $310000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 82.96% year-over-year to $310000.0 in Q1 2026; TTM through Mar 2026 was -$443000.0, a 6.74% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 136.42% from the prior year.
- Change in Account Payables for Q1 2026 stood at $310000.0, up from -$933000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for RNAC reached as high as $2.8 million in Q4 2023 and fell as low as -$2.4 million in Q3 2024.
- Historically, Change in Account Payables has averaged $80882.4 across 5 years, with a median of $85000.0 in 2023.
- Across the five-year window, Change in Account Payables soared 4050.0% in 2023 and sank 2923.53% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $102000.0 in 2022, then soared by 2643.14% to $2.8 million in 2023, then plunged by 108.47% to -$237000.0 in 2024, then tumbled by 293.67% to -$933000.0 in 2025, then surged by 133.23% to $310000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $310000.0 in Q1 2026, -$933000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | 310,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,000.00 |
| Mar 31, 2026 | 310,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | -237,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |